Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells 16,300 Shares of Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 16,300 shares of the firm’s stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $24.74, for a total value of $403,262.00. Following the completion of the transaction, the insider owned 6,881,464 shares in the company, valued at $170,247,419.36. The trade was a 0.24% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

OrthoPediatrics Price Performance

KIDS stock traded down $0.47 during midday trading on Wednesday, reaching $24.03. The company had a trading volume of 169,608 shares, compared to its average volume of 171,545. OrthoPediatrics Corp. has a 1-year low of $14.42 and a 1-year high of $26.74. The stock has a 50 day moving average price of $21.11 and a 200-day moving average price of $18.53. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17. The company has a market capitalization of $627.42 million, a price-to-earnings ratio of -14.30 and a beta of 0.98.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The firm had revenue of $70.51 million for the quarter, compared to the consensus estimate of $68.21 million. Equities research analysts expect that OrthoPediatrics Corp. will post -1.14 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on KIDS shares. Truist Financial set a $22.00 price target on OrthoPediatrics in a research note on Wednesday, August 5th. BTIG Research upped their price objective on OrthoPediatrics from $24.00 to $29.00 and gave the stock a “buy” rating in a research report on Thursday, August 20th. TD Cowen reaffirmed a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. Weiss Ratings upgraded OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 5th. Finally, Piper Sandler reissued an “overweight” rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. Nine investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $26.44.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. BlackRock Inc. bought a new position in shares of OrthoPediatrics in the 2nd quarter valued at $24,347,000. Millennium Management LLC boosted its holdings in shares of OrthoPediatrics by 48.0% during the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock valued at $24,802,000 after acquiring an additional 452,840 shares in the last quarter. AIGH Capital Management LLC bought a new stake in OrthoPediatrics during the 2nd quarter worth $5,161,000. Nantahala Capital Management LLC acquired a new stake in shares of OrthoPediatrics during the second quarter valued at about $4,636,002,000. Finally, AWM Investment Company Inc. acquired a new stake in shares of OrthoPediatrics during the second quarter valued at about $4,537,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.